Skip to content

Author

Angelo Fassio

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Atypical adult polyarteritis nodosa unmasking deficiency of adenosine deaminase 2: a case report about the importance of genetic testing in adults.

Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive autoinflammatory disorder caused by biallelic mutations in the ADA2 gene. It presents as a monogenic vasculitis with heterogeneous manifestations that often resemble small- and medium-vessel vasculitis, particularly polyarteritis nodosa (PAN)-like di...

Sofia Antolini, D. Cassandrini, S. Bindoli et al. · 0 citations
Open access Sep 2026

Real-world effectiveness and safety of secukinumab in giant cell arteritis: an Italian multicentre cohort study.

In this multicentre real-world cohort of patients with GCA, including those with relapsing disease and previous biologic exposure, secukinumab was associated with high observed remission rates, progressive GC dose reduction and increasing GC-free remission.

Luca Iorio, Federica Davanzo, C. Ricordi et al. · 0 citations
Open access Aug 2026

Long-term effects of denosumab: a 10-year single-center retrospective study

Osteoporosis weakens bones and increases the risk of fractures. Denosumab is a medication that reduces bone loss and increases bone mineral density (BMD). In this real-world study, we followed patients who received denosumab every 6 months for 10 years. We found that bone density continued to improve throughout treatme...

F. Aldegheri, Matteo Appoloni, Nicolò Passoni et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.